Evaluation of Cardiovascular Disease Risk in Patients with Type 2 Diabetes Mellitus Using Clinical Laboratory Markers

Battamir Ulambayar,Amr Sayed Ghanem,Nguyen Minh Chau,Eszter Vargáné Faludi,Marianna Móré,Attila Csaba Nagy
DOI: https://doi.org/10.3390/jcm13123561
IF: 3.9
2024-06-19
Journal of Clinical Medicine
Abstract:Background: Cardiovascular diseases (CVD) are the main cause of death in the population with diabetes mellitus. This study purposed to determine clinical laboratory markers that might be correlated with the risk of CVD in individuals with type 2 diabetes mellitus (T2DM). Methods: Using data from the Clinical Center of the University of Debrecen from 2016 to 2020, we assessed cardiovascular risk in 5593 individuals with T2DM over a five-year follow-up period. There were 347 new cases of acute myocardial infarction (AMI) and stroke during the period. Following the stratification of these individuals into two groups according to the diagnosis of these CVDs until 2020, the risk of these CVDs was assessed through the utilization of the Chi-square test and Cox proportional hazards regression. Results: The findings of the Cox proportional hazards regression model showed that the number of HbA1C measurements per year (HR = 0.46, 95% CI 0.31–0.7), decreased levels of estimated glomerular filtration rate (eGFR) (HR = 1.6, 95% CI 1.04–2.47), and elevated triglyceride levels (HR = 1.56, 95% CI 1.06–2.29) were correlated with CVD in patients with T2DM. The area under the curve (AUC) was increased from 0.557 (95% CI 0.531–0.582) to 0.628 (95% CI 0.584–0.671) after the inclusion of the laboratory variables into the model showing improved discrimination for AMI and stroke. Conclusions: These findings indicated that eGFR, triglyceride, and the number of HbA1C per year are correlated with AMI and stroke in patients with T2DM.
medicine, general & internal
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate whether clinical laboratory indicators can be used as predictors for assessing the risk of cardiovascular diseases (CVD) in patients with type 2 diabetes mellitus (T2DM), especially the risk of acute myocardial infarction (AMI) and stroke. Specifically, the study aims to identify clinical laboratory indicators related to the CVD risk in T2DM patients, including parameters of glucose metabolism, lipid profile, and renal function tests. ### Research Background Cardiovascular disease (CVD) is the leading cause of death among the diabetic (DM) population. In Europe, CVD is a major public health challenge, with an annual economic burden of up to 282 billion euros. The situation is particularly severe in Hungary, where ischemic heart disease and stroke are the leading causes of death. Although the incidence of CVD has declined in recent years, the CVD risk in T2DM patients is still higher than that in non - diabetic patients. ### Research Objectives This study aims to evaluate whether these indicators are related to the cardiovascular disease risk in T2DM patients by analyzing clinical laboratory indicators. Specific objectives include: - Determining which clinical laboratory indicators may be related to the cardiovascular disease risk in T2DM patients. - Evaluating the effectiveness of these indicators in predicting CVD events (such as AMI and stroke). ### Research Methods - **Data Sources**: The study used data from the Clinical Center of the University of Debrecen between 2016 and 2020, covering 5,593 T2DM patients. - **Research Design**: A longitudinal design was adopted, with a follow - up period of five years. - **Statistical Analysis**: Chi - square test and Cox proportional - hazards regression model were used for statistical analysis to evaluate the association between laboratory indicators and CVD events. ### Main Findings - **Renal Function Indicators**: Patients with an estimated glomerular filtration rate (eGFR) lower than 90 mL/min/1.73 m² had a 1.6 - fold increase in CVD risk (HR = 1.6, 95% CI: 1.04–2.47). - **Lipid Indicators**: Elevated triglyceride levels were associated with a 1.56 - fold increase in CVD risk (HR = 1.56, 95% CI: 1.06–2.29). - **HbA1C Measurement Frequency**: Patients who had their HbA1C measured twice a year had a 54% reduction in the risk of AMI and stroke (HR = 0.46, 95% CI: 0.31–0.7). - **Other Indicators**: Low serum creatinine levels had a protective effect on cardiovascular risk (HR = 0.44, 95% CI: 0.21–0.96). ### Conclusions The study results indicate that eGFR, triglyceride levels, and the number of HbA1C measurements per year are important predictors for the occurrence of AMI and stroke in T2DM patients. These findings are helpful for early identification of high - risk patients and taking corresponding preventive measures, thereby reducing the incidence and mortality of cardiovascular complications.